Sign in

Filings

Finds words inside filing documents. Searching Serina Therapeutics, Inc.'s filings · 53 documents indexed.

17 documents · 50 matches

  1. SER Serina Therapeutics, Inc. 10-K 2026-03-25

    Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will
    12 matches in this document

  2. SER Serina Therapeutics, Inc. 10-Q 2025-11-13

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will
    5 matches in this document

  3. SER Serina Therapeutics, Inc. 10-Q 2025-08-11

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will
    5 matches in this document

  4. SER Serina Therapeutics, Inc. 10-Q 2025-05-08

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will
    5 matches in this document

  5. SER Serina Therapeutics, Inc. 10-Q 2026-08-13

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will
    7 matches in this document

  6. SER Serina Therapeutics, Inc. 10-Q 2026-05-14

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will
    5 matches in this document

  7. SER Serina Therapeutics, Inc. 8-K 2026-09-09

    going concern; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory
    1 match in this document

  8. SER Serina Therapeutics, Inc. 8-K 2026-08-13

    going concern; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory
    1 match in this document

  9. SER Serina Therapeutics, Inc. 8-K 2026-07-22

    going concern, and competitive developments. These risks, as well as other risks, are more fully discussed in the Company’s Annual
    1 match in this document

  10. SER Serina Therapeutics, Inc. 8-K 2026-05-14

    going concern; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory
    1 match in this document

  11. SER Serina Therapeutics, Inc. 8-K 2026-03-25

    going concern; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory
    1 match in this document

  12. SER Serina Therapeutics, Inc. 8-K 2026-03-23

    going concern; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory
    1 match in this document

  13. SER Serina Therapeutics, Inc. 8-K 2026-01-28

    going concern; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory
    1 match in this document

  14. SER Serina Therapeutics, Inc. 8-K 2026-01-15

    going concern; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory
    1 match in this document

  15. SER Serina Therapeutics, Inc. 8-K 2025-12-10

    going concern; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory
    1 match in this document

  16. SER Serina Therapeutics, Inc. 8-K 2025-11-13

    going concern; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory
    1 match in this document

  17. SER Serina Therapeutics, Inc. 8-K 2025-08-11

    going concern; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory
    1 match in this document

Page 1 of 1 · 17 documents